|
|
|
| home > white papers > Autoinjector testing made safe efficient and flexible - ZwickRoell |
|
|
 WHITE PAPERS |
|
ZwickRoell
|
|
Autoinjector testing made safe efficient and flexible
|
|
The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Aptar Pharma Co Organizer and Diamond Sponsor of RDD Europe 2019 Conference in Estoril Portugal
Crystal Lake, Illinois, March 21, 2019
Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDDŽ) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.
More info >> |
|
 |
White Papers |
 |
|
Challenges of Analytical Method Transfer in the Pharmaceutical Industry
RSSL
The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >> |
|
 |
Industry Events |
 |
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
13-14 May 2019, Copthorne Tara Hotel, London, UK
SMi is delighted to announce its 3rd Annual Highly Potent
Active Pharmaceutical Ingredients conference coming to London on the 13th-14th
May 2019.
The HPAPI global market has developed rapidly in the past
year and is continuing to expand into the future, with over a quarter of drugs
in development worldwide being classified as highly potent. As a result, there
is a growing demand for both pharmaceutical and contracted manufacturers to
adapt to the evolving HPAPI landscape.
More info >> |
|
|
|
